secwatch.observer — SEC 8-K summary
======================================

Issuer:     AdaptHealth Corp. (AHCO)
CIK:        0001725255
Form:       8-K
Filed at:   2023-02-27T23:59:59+00:00
Accession:  0001628280-23-005273
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AdaptHealth reports Q4 net loss, cuts 2023 guidance on cost pressures and revenue mix
--------------------------------------------------------------------------------

- Full-year 2022 net revenue up 21% YoY; net income $69.3M ($0.33/diluted) vs $156.2M ($0.67) in 2021.
- Q4 net loss $2.6M ($(0.02)/share) vs net income $22.9M ($0.15) in Q4 2021; adjusted EBITDA $146.0M, down 7.7% YoY.
- 2023 guidance cut: revenue $3.160B-$3.240B (prev $3.210B-$3.290B); adj. EBITDA $650M-$710M (prev $690M-$750M).
- CEO cites larger-than-expected revenue mix and cost pressures for EBITDA miss; new cost containment programs planned.
- Cash flow from operations $373.9M in 2022, up from $275.7M in 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/0001628280-23-005273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725255/000162828023005273/ahco-20230227.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-005273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer